COVID-19: situation of authorized clinical trials Spain 2021

Published by Statista Research Department, May 9, 2025
As of January 7, 2021, over 140 clinical trials had been authorized in Spain to evaluate the efficacy of various treatments against the coronavirus. Of these, approximately 30 percent had not yet started, while 5.6 percent had been completed.
Log in or register to access precise data.

Percentage distribution of clinical trials of coronavirus treatments authorized in Spain as of January 2021, by trial situation

CharacteristicPercentage of trials
- -
- -
- -
- -
Showing entries 1 to 4 (4 entries in total)
Statistic: Percentage distribution of clinical trials of coronavirus treatments authorized in Spain as of January 2021, by trial situation

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2021

Region

Spain

Survey time period

January 7, 2021

Open this statistic in...
Spanish
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus: the pharma and medtech response "

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus (COVID-19) in FinlandCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) in the Nordics Coronavirus (COVID-19) in Sweden
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.